Oviva
Kai Eberhardt is the co-founder and CEO of Oviva. Kai has a background in launching and supporting innovative medical products, focused on reimbursement, market access, and sales. Kai was an associate principal at McKinsey & Company from March 2012 to December 2014.
Kai Eberhardt received a PhD in Physical Chemistry from ETH Zürich and an MS in Physics from ETH Zürich. Kai also received training in Medical Physics at Harvard Medical School.
Some direct reports include David Nydegger - Chief Product Officer, Anna Haas - Managing Director, Germany, and Richard Etter - Managing Director, Switzerland.
This person is not in any offices
Oviva
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform.